NO- Залежні механізми розладів окиснювального метаболізму головного мозку щурів при порушенні утворення мелатоніну

197. Ghafourifar P. Nitric oxide synthase activity in mitochondria / P. Ghafourifar, C. Richter // FEBS Lett. - 1997. - V. 418. - P. 291-296.

198. Giacomo B. Synthesis and biological activity of new melatonin dimeric derivatives / В. Giacomo, А. Bedini, G . Spadoni // Bioorg. Med. Chem. - 2007. -V. 15. - P. 4643-4650.

199. Giulivi C. Production of nitric oxide by mitochondria / C. Giulivi, J.J. Poderoso, A. Boveris // J. Biol. Chem. - 1998. - V. 273. - P. 11038-11043.

200. Gloire G. NF-kappaB activation by reactive oxygen species: fifteen years later G. Gloire, S. Legrand-Poels, J. Piette // Biochem. Pharmacol. - 2006. - V. 72, № 11. - P. 1493-1505.

201. Gochman E. NF-?B activation by peroxynitrite through I?B?-dependent phosphorylation versus nitration in colon cancer cells / E. Gochman, J. Mahajna, A.Z. Reznick // Anticancer Res. - 2011. - V. 31, № 5. - P. 1607-1617.

202. Guerrero J.M. Melatonin prevents increases in neuronal nitric oxide and cyclic GMP production after transient brain ischemia and reperfusion in the Mangolian gerbil / J.M. Guerrero, R.J. Reiter, G. Ortiz // J.Pineal Res. - 1997. - V. 23. - Р. 24-31.

203. Guttridge D.C. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1 / D.C. Guttridge, C. Albanese, J.Y. Reuther et al. Mol.Cell. Biol. - 1999. - V. 19. - P. 5785-5799.

204. Hardeland R. Melatonergic drugs in clinical practice / R. Hardeland, B. Poeggeler, V. Srinivasan // Arzneimittelforschung. - 2008. - V. 58, № 1. - P. 1-10.

205. Hardeland R. Melatonin, hormone of darkness and more: occurrence, control mechanisms, actions and bioactive metabolites / R. Hardeland // Cell. Mol. Life. Sci. - 2008. - V. 65, № 13. - P. 2001-2018.

206. Hardeland R. Melatonin: signaling mechanisms of a pleiotropic agent/ R. Hardeland // Biofactors. - 2009. - V. 35, № 2. - P. 183-192.

207. Hardeland R. New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists / R. Hardeland // Neuropsychiatr. Dis. Treat. - 2009. - № 5. - P. 341-354.

208. Hayakawa M. Evidence that reactive oxygen species do not mediate NF-kappaB activation / M. Hayakawa, H. Miyashita, I. Sakamoto [et al.] // EMBO J. - 2003. - V.22. - № 13. - P. 3356-3366.

209. Hevel J.M. Purification of the inducible murene macrophage nitric oxide synthase / J.M. Hevel // J Biol Chem. - 1991. - V. 266, № 34. - Р. 22789-22791.

210. Heusch P. Increased inducible nitric oxide synthase and arginase II expression in heart failure: no net nitrite/nitrate production and protein S-nitrosylation / P. Heusch, S. Aker, K. Boengler [et al.] // Am. J. Physiol. Heart Circ. Physiol. - 2010. - V. 299, № 2. - P. H446-H453.

211. Hooper D.C. Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis / D.C. Hooper, G.S. Scott, A. Zborek [et al.] // FASEB J. - 2000. V. 14, № 5. - P. 691-698.

212. Huang Z. Enzymatic function of hemoglobin as a nitrite reductase that produces NO under allosteric control / Z. Huang, S. Shiva, D.B. Kim-Shapiro [еt al.] // J. Clin. Invest. - 2005. - V. 115, № 8. - P. 2099-2107.

213. Huk I. L-arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia/reperfusion injury in skeletal muscle / I. Huk, J. Nanobashvili, C. Neumayer [et al.] // Circulation. - 1997. - V. 96. - P. 667-675.

214. Jaworeck D. Adenosin-5'-diphosphat und adenosin-5'-monophosphat / D. Jaworeck, W. Gruber, H.V. Bermeyer // Methoden der enzymatischen analyse. - Bd.II. - Weinheim : Verlag - Chemie, 1974. - S. 2147-2151.

215. Jockers R. Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new? / R. Jockers, P. Maurice, J.A. Boutin // Br. J. Pharmacol. 2008. - V. 154, № 6. - P. 1182-1195.

216. Kalinowski L. Endothelial NADH/NADPH-dependent enzymatic sources of superoxide production: relationship to endothelial dysfunction / L. Kalinowski, T. Malinski // Acta Biochim. Pol. - 2004. - V. 51, № 2. - Р. 459-469.

217. Kaltschmidt B. Signaling via NF-kappaB in the nervous system / B. Kaltschmidt, D. Widera, C. Kaltschmidt // Biochim. Biophys. Acta. - 2005. - V. 1745, № 3. - P. 287-299.

218. Kamat J.P. Peroxynitrite: a potent oxidizing and nitrating agent / J.P. Kamat // Indian J. Exp. Biol. - 2006. - V. 44, № 6. - P. 436-447.

219. Kanner J. Nitric oxide as an antioxidant / J. Kanner, S. Harel, R. Granit // Arch. Biochem. Biophys. - 1991. - V. 289. - P. 130-135.

220. Karim A. Disposition kinetics and tolerance of escalating single doses of ramelteon, a high affinity MT1 and MT2 melatonin receptor agonist indicated for the treatment of insomnia / A. Karim, D. Tolbert, C. Cao // J. Clin. Pharmacol. - 2006. - V. 46. - P. 140-148.

221. Kilic E. Pinealectomy aggravates and melatonin administration attenuates brain damage in focal ischemia / E. Kilic, Y. Ozdemir, H. Bolay // J. Cerebr. Blood Flow Metabol. - 1999. - V. 19. - Р.511-516.

222. Kim J.H. Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats / J.H. Kim, L.J. Bugaj, Y.J. Oh [et al.] J. Appl. Physiol. - 2009. - V. 107, № 4. - P. 1249-1257.

223. Klein D.C. Arylalkylamine N-acetyltransferase: “the Timezyme” / D.C. Klein J. Biol. Chem. - 2007. - V. 282. - P. 4233-4237.

224. Kokkola T. Inverse agonist exposure enhances ligand binding and G protein activation of the human MT1 melatonin receptor, but leads to receptor down-regulation / Т. Kokkola, М. Vaittinen, J.T. Laitinen // J. Pineal Res. - 2007. - V. 43, № 3. - P. 255-262.

225. Kondoh T. Melatonin reduces cerebral edema formation caused by transient forebrain ischemia in rats / Т. Kondoh, N. Uneyama, Н. Nishino // Life Sci. -2002. V. 72. - Р. 583-590.

226. Korkmaz A. Role of melatonin in metabolic regulation/ А. Korkmaz, Т. Topal, D.X. Tan // Rev. Endocr. Metab. Disord. - 2009. - V. 10, № 4. - P. 261-270.

227. Kotsyuba A.E. Nitroxidergic nerve fibers of intracerebral vessels / A.E. Kotsyuba, E.P. Kotsyuba, V.M. Chertok // Neurosci Behav. Physiol. - 2010. - V. 40, № 4. - P. 451-455.

228. Kozlov A.V. Nitrite reductase activity is a novel function of mammalian mitochondria / A.V. Kozlov, K. Staniek, H. Nohl // FEBS Lett. - 1999. - V. 454, № 1-2. - P. 127-130.

229. Kuanczyk E. The effect of melatonin on antioxidant enzymes in human diabetic skin fibroblasts / E. Kuanczyk, M. Bryszewsha // Cell. Mol. Biol. Lett. -2003. - V. 8, № 2. - Р. 333-336.

230. Kumar A. JSH-23 targets nuclear factor-kappa B and reverses various deficits in experimental diabetic neuropathy: effect on neuroinflammation and antioxidant defence / A. Kumar, G. Negi, S.S. Sharma // Diabetes Obes. Metab. - 2011. - V. 13, № 8. - P. 750-758.

231. Kurt T. Effects of L-arginine on the brain ischaemia reperfusion damage in rats: An investigation by somatosensory evoked potentials and histopathology / T. Kurt MD1, A. Oguzhanoglu, R. Ortac [et al.] // Neuroscі. Res. Comm. - 2002. - V. 31, № 3. - P. 175-182.

232. Kwon N.S. Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide / N.S. Kwon, D.J. Stuehr, C.F. Hathan // J. Exp. Med. - 1991. V. 174, № 4. - P. 761-767

233. Lamprecht W. ATP; Bestimmung mit Hexokinase und Glucose-6-phosphat - Dehydrogenase / W. Lamprecht, I. Trautschold // Methoden der enzymatischen Analyse. - Bd. II. - Weinheim : Verlag - Chemie, 1974. - S. 2151-2159.

234. Laude K. NO produced by endothelial NO synthase is a mediator of delayed preconditioning-induced endothelial protection / K. Laude, J.Favre, C. Thuillez [et al.] // Am J Physiol Heart Circ Physiol. - 2003. - V. 284, № 6. - P. 2053-2060.

235. Lee E.J. Melatonin attenuates gray and white matter damage in a mouse model of transient focal cerebral ischemia / E.J. Lee, M.Y. Lee, H.Y. Chen [et al.] J. Pineal. Res. - 2005. - V. 38, № 1. - P. 42-52.

236. Leon J. Inhibition of neuronal nitric oxide synthase activity by N1 -acetyl-5-methoxykynuramine, a brain metabolite of melatonin / J. Leon, G. Escames, M.I. Rodriguez [et al.] // J. Neurochem. - 2006. - V. 98. - P. 2023-2033.

237. Leon J. Melatonin mitigates mitochondrial malfunction / J. Leon, D.A. Castroviejo, G. Escames, D.-X. Tan // J. Pineal Res. - 2005. - V. 38. - P. 1-9.

238. Levoye A. The orphan GPR50 receptor specifically inhibits MT(1) melatonin receptor function through heterodimerization / А. Levoye, J. Dam, M.A. Ayoub // EMBO J. - 2006. - V. 25. - P. 3012-3023.

239. Lima T. Effects of melatonin on temporal lobe epilepsy: study through the experimental model induced by pilocarpine / T. Lima, J.M. Soares, Y.C.S. Garrido// Epilepsia. - 2004. - V. 44 (Suppl. 3). - P. 55.

240. Listwak S.J. Minimal NF-?B activity in neurons / S.J. Listwak, P. Rathore, M. Herkenham // Neuroscience. - 2013. - V. 250. - P. 282-299.

241. Luiking Y.C. Arginine de novo and nitric oxide production in disease states / Y.C. Luiking, G.A. Ten Have, R.R. Wolfe [et al.] // Am. J. Physiol. Endocrinol. Metab. - 2012. - V. 303, № 10. - P. E1177-E1189.

242. Lundberg J.O. Nitrate and nitrite in biology, nutrition and therapeutics / J.O. Lundberg, M.T. Gladwin, S. Shiva [et al.] // Nature Chem. Biol. - 2009. - V. 5, №12. - P. 865-869.

243. Lundberg J.O. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics / J.O. Lundberg, E. Weitzberg, M.T. Gladwin // Nature reviews. - 2008. - V. 7. - P. 156-167.

244. Mailliet F. Characterization of the melatoninergic MT3 binding site on the NRH:quinone oxidoreductase 2 enzyme / F. Mailliet, G. Ferry, F. Vella // Biochem. Pharmacol. - 2005. - V. 71. - P. 74-88.

245. Maldonado M.D. The role of melatonin in the immuno-neuro-psychology of mental disorders / M.D. Maldonado, M.A. Perez-San-Gregorio, R.J. Reiter // Recent. Pat. CNS Drug. Discov. - 2009. - V. 4, № 1. - P.61-69.

246. Mariappan N. NF-?B-induced oxidative stress contributes to mitochondrial and cardiac dysfunction in type II diabetes / N. Mariappan, C.M. Elks, S. Sriramula [et al.] // Cardiovasc. Res. - 2010. - V. 85. - P. 473-483.

247. Mattson M.P. Roles for NF-kappaB in nerve cell survival, plasticity, and disease / Mattson M.P., Meffert M.K. // Cell Death. Differ. - 2006. - V. 13, № 5. - P. 852-860.

248. Mattson M.P. NF-kappaB in the survival and plasticity of neurons / Mattson M.P. // Neurochem. Res. - 2005. - V. 30, № 6-7. - P. 883-893.

249. Memet S. NF-kappaB functions in the nervous system: from development to disease / S. Memet // Biochem. Pharmacol. - 2006. - V. 72, № 9. - P. 1180-1195.

250. Mesenge C. Neuroprotection by melatonin in mice submitted to brain injury / C. Mesenge, C. Verrecchia, R.G. Boulu // Naunyn. Schmiedeberg's Arch. Pharmacol. - 1998. - V. 358. - Р. 32.

251. Monzani E. Binding of nitrite and its reductive activation to nitric oxide at biomimetic copper centers / E. Monzani, G.J. Anthony, A. Koolhaas [et al.] // J. Biol. Inorg. Chem. - 2000. - V. 5, № 2. - P. 251-261.

252. Niles L.P. Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT 1 receptors with neuronal and glial markers / L.P. Niles, K.J. Armstrong, L.M. Rincon Castro // BMC Neurosci. - 2004. - V. 5. - Р. 41-50.

253. Nitric Oxide, Second Edition: Biology and Pathobiology / L.J. Ignarro ed. - 2nd ed. - N.Y. : Science Press, 2009. - 845 p.

254. Nohl H. The existence and significance of a mitochondrial nitrite reductase / H. Nohl, K. Staniek, A.V. Kozlov // Redox Rep. - 2005. - V. 10, № 6. - P. 281-286.

255. Okatani Y. Melatonin increases activities of glutathione peroxidase and superoxide dismutase in fetal rat brain / Y. Okatani, A. Wakatsuki, C. Kaneda // J. Pineal. Res. - 2000. - V. 28, № 2. - P. 89-96.

256. Oktem G. Evaluation of the relationship between inducible nitric oxide synthase (iNOS) activity and effects of melatonin in experimental osteoporosis in the rat / G. Oktem, S. Uslu, S.H. Vatansever [et al.] // Surg. Radiol. Anat. - 2006. - V. 28. - P. 157-162.

257. Olivieri G. Beta-amyloid modulates tyrosine kinase B receptor expression in SH SY SY neuroblastome cells: influence of the antioxidant melatonin / G. Olivieri, U. Otten, F. Meier // Neurosci. - 2003. - V. 120. - Р. 659-665.

258. Ozturk G. The effect of melatonin on liver superoxide dismutase activity, serum nitrate and thyroid hormone levels / G. Ozturk, S. Coskun, D. Erbas [et al.] / Jpn J. Physiol. - 2000. - V. 50, № 1. - P. 149-153.

259. Pandi-Perumal S.R. Physiological effects of melatonin: Role of melatonin receptors and signal transduction pathways / S.R. Pandi-Perumal, I. Trakht, V. Srinivasan // Prog. Neurobiol. - 2008. - V. 85. - P. 335-353.

260. Pearce L.L. Nitrosative stress results in irreversible inhibition of purified mitochondrial complexes I and III without modification of cofactors / L.L. Pearce, A.J. Kanai, M.W. Epperly [et al.] // Nitric Oxide. - 2005. - V. 13. - P. 254-263.

261. Pei Z. Administration of melatonin after onset of ischemia reduces the volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model / Z. Pei, S.F. Pang, T.F. Cheung // Stroke - 2003. - V. 32. - Р. 770-775.

262. Persichini T. Interleukin-1? induces ceruloplasmin and ferroportin-1 gene expression via MAP kinases and C/EBP?, AP-1, and NF-?B activation / T. Persichini, N. Maio, M.C. di Patti [et al.] // Neurosci Lett. - 2010. - V. 484, № 2. - P. 133-138.

263. Pizzi M. Distinct roles of diverse nuclear factor-kappaB complexes in neuropathological mechanisms / M. Pizzi, P. Spano // Eur. J. Pharmacol. - 2006. - V. 545, № 1. - P. 22-28.

264. Punsawad C. Nuclear factor kappa B modulates apoptosis in the brain endothelial cells and intravascular leukocytes of fatal cerebral malaria / C. Punsawad, Y. Maneerat, U. Chaisri [et al.] // Malar. J. - 2013. - V. 12. - P. 260.

265. Qu X.-W. Neuronal nitric oxide synthase (NOS) regulates the expression of inducible NOS in rat small intestine via modulation of nuclear factor kappa B / X.-W. Qu, H. Wang, I.G. de Plaen [et al.] // FASEB. - 2001. -V. 15. - P. 439-446.

266. Radi R. Peroxynitrite reactions and formation in mitochondria / R. Radi, A. Cassina, R. Hodara [et al.] // Free Radic. Biol. Med. - 2002. - V. 33. - P. 1451-1464.

267. Regriny O. Melatonin improves cerebral circulation security margin in rats / O. Regriny, P. Delagrange, E. Scalbert // Am. J. Physiol. - 1998. - V. 275. -Р. 139-134.

268. Reiter R.J. Melatonin and reproduction revisited / R.J. Reiter, D.K. Tan, L.C. Manchester // Biol. Reprod. - 2009. - V. 81, № 3. - P. 445-456.

269. Reiter R.J. Melatonin: Lowering the High Price of Free radicals / R.J. Reiter // News Phisiol. Sci. - 2000. - V. 15. - P. 246-250.

270. Reiter R.J. The aging pineal gland and its physiological consequences / R.J. Reiter //Bio Essays - 1992. - V.14. - Р. 169-175.

271. Reiter R.J. The circadian melatonin rhythm and its modulation: possible impact on hypertension / R.J. Reiter, D.K. Tan, A. Korkmaz // J. Hypertens. - 2009. - V. 6. - P. 17-20.

272. Reiter R.J. When melatonin gets of your nerves: its beneficial actions in experimental models of stroke / R.J. Reiter, D.K. Tan, J. Leon // Exp. Biol. Med. - 2005. - V. 230. - Р. 104-117.

273. Reiter R.J. What constitutes a physiological concentration of melatonin? / R.J. Reiter, D.K. Tan // J. Pineal Res. - 2003. - V. 34. - Р. 79-80.

274. Resuehr D. Exploratory investigation of the effect of melatonin and calorik restriction on the temporal expression of murine hypothalamic transcripts / D. Resuehr., H.E. Sikes, J.J. Olcese / Neuroendocrinol. - 2006. - V. 18, № 4. - Р. 279-289.

275. Rivara S. Melatonin receptor agonists: SAR and applications to the treatment of sleep-wake disorders / S. Rivara, M. Mor, A. Bedini // Curr. Top. Med. Chem. - 2008. - V. 8, № 11. - P. 954-968.

276. Rodriguez A.B. Melatonin controls superoxide anion level: modulation of superoxide dismutase activity in ring dove heterophils / A.B. Rodriguez, G. Nogales, E. Ortega [et al.] // J Pineal. Res. - 1998. - V. 24, № 1. - P. 9-14.

277. Rohrenbeck A.M. Peroxynitrite dependent response to neurotropic virus infection is the central nervous system inflammatory / A.M. Rohrenbeck, B. Dietzschold, E. Spitsin [et al.] // J. Immunol. - 2001. - V. 167. - P. 3470-3477.

278. Romano A. Evolutionarily-conserved role of the NF-kappaB transcription factor in neural plasticity and memory / A. Romano, R. Freudenthal, E. Merlo, [et al.] // Eur. J. Neurosci. - 2006. - V. 24, № 6. - P. 1507-1516.

279. Sankaralingam S. Arginase contributes to endothelial cell oxidative stress in response to plasma from women with preeclampsia / S. Sankaralingam, H. Xu, S.T. Davidge // Cardiovasc. Res. - 2010. - V. 85, № 1. - P. 194-203.

280. Sarnico I. NF-kappaB dimers in the regulation of neuronal survival / Sarnico I., Lanzillotta A., Benarese M. [et al.] // Int. Rev. Neurobiol. - 2009. - V.85. - P. 351-362.

281. Sarti P. New evidence for cross talk between melatonin and mitochondria mediated by a circadian-compatible interaction with nitric oxide / P. Sarti, M.C. Magnifico, F. Altieri [et al.] // Int. J. Mol. Sci. - 2013. - V. 14, № 6. - P. 11259-11276.

282. Savasakan E. Melatonin in aging and neurodegeneration / E. Savasakan // Drug Develop. Res. - 2002. - V. 56. - P. 482-490.

283. Schomerus C. Activation of arylalkilamine N-acetyltransferase byphorbol esters in bovine pinealocytes suggests a novel regulatory pathway in melatonin / С. Schomerus, Е. Laedtke, J.H. Korf // J. Neuroendocrinol. - 2004. - V. 16, № 9. - Р. 740-749.

284. Sethi S. C-terminal domains within human MT1 and MT2 melatonin receptors are involved in internalization processes / S. Sethi, W. Adams, J. Pollock J. Pineal Res. - 2008. - V. 45. - P. 212-218.

285. Shiva S. Mitochondria as metabolizers and targets of nitrite / S. Shiva // Nitric Oxide. - 2010. - V. 22, № 2. - P. 64-74.

286. Shiva S. Nitric oxide partitioning into mitochondrial membranes and the control of respiration at cytochrome c oxidase / S. Shiva, P.S. Brookes, R.P. Patel [et al.] // Proc Nat Acad Sci USA. - 2001. - V. 98, № 13. - P. 7212-7217.

287. Simile M.M. Chemopreventive N-(4-hydroxyphenyl)retinamide (fenretinide) targets deregulated NF-?B and Mat1A genes in the early stages of rat liver carcinogenesis / M.M. Simile, G. Pagnan, F. Pastorino [еt al.] // Carcinogenesis. - 2005. - V. 26, № 2. - P. 417-427.

288. Sinha K. Effect of melatonin on ischemia/reperfusion injury induced by middle cerebral artery occlusion in rats / K. Sinha, M.N. Degaonkar, N.R. Jagannathan // Eur. J. Pharmacol. - 2002. - V. 428. - Р. 185-192.

289. Siomek A. NF-?B signaling pathway and free radical impact / A. Siomek // Acta Biochim. Pol. - 2012. - V. 59, № 3. - P. 323-331.

290. Skene D.J. Melatonin rhythmicity: effect of age and Alzheimer disease / D.J. Skene, D.F. Swaab // Exp. Gerontol. - 2003. - V. 38. - Р. 199-206.

291. Solan N.J. RelB cellular regulation and transcriptional activity are regulated by p100 / N.J. Solan, H. Miyoshi, E.M. Carmona [et al.] // J. Biol. Chem. - 2002. - V. 277, № 2. - P. 1405-1418.

292. Srinivasan V. Immunomodulation by melatonin: its significance for seasonally occurring diseases / V. Srinivasan, D.W. Spence, I. Trakht // Neuroimmunomodulation. - 2008. - V. 15, № 2. - P. 93-101.

293. Srinivasan V. Melatonin, immune function and aging/ V. Srinivasan, G.J. Maestroni, D.F. Cardinali // Immun.Aging. - 2005. - V. 2. - Р. 17-27.

294. Srinivasan V. Melatonin in mitochondrial dysfunction and related disorders / V. Srinivasan, D.W. Spence, S.R. Pandi-Perumal [et al.] // Int. J. Alzheimers Dis. - 2011. - V. 2011. - Publ. 320-326.

295. Srinivasan V. Pathophysiology of depression: role of sleep and the melatonergic system / V. Srinivasan, S.R. Pandi-Perumal, I. Trakht // Psychiatry Res. - 2009. - V. 165, № 3. - P. 201-214.

296. Srinivasan V. Therapeutic actions of melatonin in cancer: possible mechanisms / V. Srinivasan, D.W. Spence, S.R. Pandi-Perumal // Integr. Cancer Ther. - 2008. - V. 7, № 3. - P. 189-203.

297. Stamler J.S. Redox signaling: nitrosylation and related target interactions of nitric oxide / J.S. Stamler // Cell. - 1994. - V. 78. - P. 931-936.

298. Sullivan P.G. Exacerbation of damage and altered NF-kappaB activation in mice lacking tumor necrosis factor receptors after traumatic brain injury / P.G. Sullivan, A.J. Bruce-Keller, A.G. Rabchevsky [et al.] // J. Neurosci. - 1999. - V. 19. - P. 6248-6256.

299. Szabo S. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics / C. Szabo, H. Ischiropoulos, R. Radi // Nature Reviews. - 2007. - V. 6. - P. 662-680.

300. Takeuchi K. Role of endogenous nitric oxide (NO) and NO synthases in healing of indomethacin-induced intestinal ulcers in rats / K. Takeuchi, R. Hatazawa, M. Tanigami [et al.] // Life Sci. - 2007. - V. 80, № 4. - P. 329-336.

301. Tan D.X. Melatonin as a naturally occurring co-substrate of quinone reductase-2, the putative MT3 melatonin membrane receptor: hypothesis and significance / D.X. Tan, L.C. Manchester, M.P. Terron // J. Pineal Res. - 2007. - V. 43, № 4. - P. 317-320.

302. Teng F.Y. NF-kappaB signaling in neurite growth and neuronal survival / F.Y. Teng, B.L. Tang // Rev. Neurosci. - 2010. - V. 21, № 4. - P. 299-313.

303. The Asymmetrical Brain / ed. by K. Hugdahl, R.J. Davidson. - Cambridge etc. : MIT Press, 2004. - 810 p.

304. Torii K. Melatonin suppresses cerebral edema caused by middle cerebral artery occlusion/reperfusion in rats assessed by magnetic resonance imaging / К. Torii, Н. Uneyama, Н. Nishino // J. Pineal Res. - 2004. - V. 36. - Р. 18-24.

305. Tornatore L. The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation / L. Tornatore, A.K. Thotakura, J. Bennett // Trends Cell Biol. - 2012. - V. 22, № 11. - P. 557-566.

306. Van der Helmvan M. No influence of melatonin on cerebral blood how in humans / M. Van der Helmvan, H.M. Annette, E. Van Someren // J. Clin. Endocrinol. Metab. - 2003. - V. 88, № 12. - Р. 5989-5994.

307. Vasquez-Vivar J. Superoxide generation by endothelial nitric oxide synthase: the in?uence of cofactors / J. Vasquez-Vivar, B. Kalyanaraman, P. Maratsek [et al.] // Proc. Natl. Acad. Sci USA. - 1998. - V. 95. - P. 9220-9225.

308. Vilar A. Melatonin suppresses nitric oxide production in glial cultures by pro-inflammatory cytokines through p38 MAPK inhibition / A. Vilar, L. de Lemos, I. Patraca [et al.] // Free Radic. Res. - 2014. - V. 48, № 2. - P. 119-128.

309. Vos T.A. Expression of inducible nitric oxide synthase in endotoxemic rat hepatocytes is dependent on the cellular glutathione status / T.A. Vos, H. Van Goor, L. Tuyt [et al.] // Hepatology. - 1999. - V. 29, № 2. - P. 421-426.

310. Walton J.C. Neuronal nitric oxide synthase and NADPH oxidase interact to affect cognitive, affective, and social behaviors in mice / J.C. Walton, B. Selvakumar, Z.M. Weil [et al.] // Behav. Brain Res. - 2013. - V. 256. - P. 320-327.

311. Wooten M.W. The atypical protein kinase C-interacting protein p62 is a scaffold for NF-kappaB activation by nerve growth factor / M.W. Wooten, M.L. Seibenhener, V. Mamidipudi [et al.] // J. Biol. Chem. - 2001. - V. 276. - P. 7709-7712.

312. Ximenes V. F. Superoxide-dependent oxidation of melatonin by myelo-peroxidase / V. F. Ximenes, S. de O. Silva, M. R. Rodrigues / Biol. Chem. - 2005. № 46. - Р. 38160-38169.

313. Yang L. Roles of NF-kappaB in central nervous system damage and repair / L. Yang, L.Y. Tao, X.P. Chen // Neurosci Bull. - 2007. - V. 23, № 5. - P. 307-313.

314. Zawilska J.B. Physiology and pharmacology of melatonin in relation to biological rhythms / J.B. Zawilska, D.J. Skene, J. Arendt // Pharm. Reports. - 2009. - V. 61, № 3. - P. 383-410.

315. Zhang X. Peroxynitrite mediated oxidation damage and cytotoxicity in biological systems / X. Zhang, D. Li // Life Sci J. - 2006. - V. 3, № 3. - P. 41-44.

316. Zhou L. Neuronal nitric oxide synthase: structure, subcellular localization, regulation, and clinical implications / L. Zhou, D.Y. Zhu // Nitric Oxide. - 2009. - V. 20, № 4. - P. 223-230.

Размещено на Allbest.ur